Vor BioPharma Inc (VOR)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$18.66-7.26%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · VOR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 97.2 | 321.5 | 93.3 | 94.3 | 64.6 | 47.5 | 31.6 |
| Operating Income | (177.4) | (371.6) | (121.2) | (126.0) | (93.4) | (69.0) | (43.4) |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 15.7 | 5.9 | 4.3 | 8.2 | 1.3 | 0.1 | 0.0 |
| Other Non-Operating Income / Expenses | 1,531.2 | (324.3) | 4.3 | 8.2 | 1.3 | 0.1 | 0.0 |
| Net Income | |||||||
| Net Income | 1,353.7 | (696.0) | (116.9) | (117.9) | (92.1) | (68.9) | (43.3) |
| Per Share | |||||||
| Basic EPS | 22.69 | (70.50) | (1.70) | (1.75) | (2.33) | (2.10) | — |
| Diluted EPS | 22.69 | (70.50) | (1.70) | (1.75) | (2.33) | (2.10) | — |
| Basic Weighted Avg Shares | 59.7 | 9.9 | 68.7 | 67.2 | 39.6 | 33.4 | — |
| Diluted Weighted Avg Shares | 59.7 | 9.9 | 68.7 | 67.2 | 39.6 | 33.4 | — |
| Supplemental | |||||||
| EBIT | (177.4) | (371.6) | (121.2) | (126.0) | (93.4) | (69.0) | (43.4) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.